Click for best price
Cellular Gene Therapy CDMO Market Size, Share 2023
This report contains market size and forecasts of Cellular and Gene Therapy CDMO in Global, including the following market information:
Global Cellular and Gene Therapy CDMO Market Revenue, 2018-2023, 2023-2032, ($ millions)
Global top five companies in 2022 (%)
The global Cellular and Gene Therapy CDMO market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2032.
Cell Therapy Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Cellular and Gene Therapy CDMO include Catalent, Lonza, Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec and Pharmaron, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cellular and Gene Therapy CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cellular and Gene Therapy CDMO Market, by Type, 2018-2023, 2023-2032 ($ millions)
Global Cellular and Gene Therapy CDMO Market Segment Percentages, by Type, 2022 (%)
Cell Therapy
Viral Vectors
Plasmid
Global Cellular and Gene Therapy CDMO Market, by Application, 2018-2023, 2023-2032 ($ millions)
Global Cellular and Gene Therapy CDMO Market Segment Percentages, by Application, 2022 (%)
Commercial
Academic Research
Others
Global Cellular and Gene Therapy CDMO Market, By Region and Country, 2018-2023, 2023-2032 ($ Millions)
Global Cellular and Gene Therapy CDMO Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cellular and Gene Therapy CDMO revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cellular and Gene Therapy CDMO revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Catalent
Lonza
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions
| Report Attributes |
Report Details |
| Report Title |
Cellular and Gene Therapy CDMO Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
118 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cellular and Gene Therapy CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cellular and Gene Therapy CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cellular and Gene Therapy CDMO Overall Market Size
2.1 Global Cellular and Gene Therapy CDMO Market Size: 2022 VS 2032
2.2 Global Cellular and Gene Therapy CDMO Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cellular and Gene Therapy CDMO Players in Global Market
3.2 Top Global Cellular and Gene Therapy CDMO Companies Ranked by Revenue
3.3 Global Cellular and Gene Therapy CDMO Revenue by Companies
3.4 Top 3 and Top 5 Cellular and Gene Therapy CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cellular and Gene Therapy CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cellular and Gene Therapy CDMO Players in Global Market
3.6.1 List of Global Tier 1 Cellular and Gene Therapy CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Cellular and Gene Therapy CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cellular and Gene Therapy CDMO Market Size Markets, 2022 & 2032
4.1.2 Cell Therapy
4.1.3 Viral Vectors
4.1.4 Plasmid
4.2 By Type - Global Cellular and Gene Therapy CDMO Revenue & Forecasts
4.2.1 By Type - Global Cellular and Gene Therapy CDMO Revenue, 2018-2023
4.2.2 By Type - Global Cellular and Gene Therapy CDMO Revenue, 2023-2032
4.2.3 By Type - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cellular and Gene Therapy CDMO Market Size, 2022 & 2032
5.1.2 Commercial
5.1.3 Academic Research
5.1.4 Others
5.2 By Application - Global Cellular and Gene Therapy CDMO Revenue & Forecasts
5.2.1 By Application - Global Cellular and Gene Therapy CDMO Revenue, 2018-2023
5.2.2 By Application - Global Cellular and Gene Therapy CDMO Revenue, 2023-2032
5.2.3 By Application - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Cellular and Gene Therapy CDMO Market Size, 2022 & 2032
6.2 By Region - Global Cellular and Gene Therapy CDMO Revenue & Forecasts
6.2.1 By Region - Global Cellular and Gene Therapy CDMO Revenue, 2018-2023
6.2.2 By Region - Global Cellular and Gene Therapy CDMO Revenue, 2023-2032
6.2.3 By Region - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Cellular and Gene Therapy CDMO Revenue, 2018-2032
6.3.2 US Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.3.3 Canada Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.3.4 Mexico Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Cellular and Gene Therapy CDMO Revenue, 2018-2032
6.4.2 Germany Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.3 France Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.4 U.K. Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.5 Italy Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.6 Russia Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.7 Nordic Countries Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.4.8 Benelux Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Cellular and Gene Therapy CDMO Revenue, 2018-2032
6.5.2 China Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.5.3 Japan Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.5.4 South Korea Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.5.5 Southeast Asia Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.5.6 India Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Cellular and Gene Therapy CDMO Revenue, 2018-2032
6.6.2 Brazil Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.6.3 Argentina Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cellular and Gene Therapy CDMO Revenue, 2018-2032
6.7.2 Turkey Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.7.3 Israel Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.7.4 Saudi Arabia Cellular and Gene Therapy CDMO Market Size, 2018-2032
6.7.5 UAE Cellular and Gene Therapy CDMO Market Size, 2018-2032
7 Players Profiles
7.1 Catalent
7.1.1 Catalent Corporate Summary
7.1.2 Catalent Business Overview
7.1.3 Catalent Cellular and Gene Therapy CDMO Major Product Offerings
7.1.4 Catalent Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.1.5 Catalent Key News
7.2 Lonza
7.2.1 Lonza Corporate Summary
7.2.2 Lonza Business Overview
7.2.3 Lonza Cellular and Gene Therapy CDMO Major Product Offerings
7.2.4 Lonza Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.2.5 Lonza Key News
7.3 Charles River
7.3.1 Charles River Corporate Summary
7.3.2 Charles River Business Overview
7.3.3 Charles River Cellular and Gene Therapy CDMO Major Product Offerings
7.3.4 Charles River Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.3.5 Charles River Key News
7.4 The Discovery Labs
7.4.1 The Discovery Labs Corporate Summary
7.4.2 The Discovery Labs Business Overview
7.4.3 The Discovery Labs Cellular and Gene Therapy CDMO Major Product Offerings
7.4.4 The Discovery Labs Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.4.5 The Discovery Labs Key News
7.5 BIOCENTRIQ
7.5.1 BIOCENTRIQ Corporate Summary
7.5.2 BIOCENTRIQ Business Overview
7.5.3 BIOCENTRIQ Cellular and Gene Therapy CDMO Major Product Offerings
7.5.4 BIOCENTRIQ Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.5.5 BIOCENTRIQ Key News
7.6 FUJIFILM Diosynth Biotechnologies
7.6.1 FUJIFILM Diosynth Biotechnologies Corporate Summary
7.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.6.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Major Product Offerings
7.6.4 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.6.5 FUJIFILM Diosynth Biotechnologies Key News
7.7 Exothera
7.7.1 Exothera Corporate Summary
7.7.2 Exothera Business Overview
7.7.3 Exothera Cellular and Gene Therapy CDMO Major Product Offerings
7.7.4 Exothera Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.7.5 Exothera Key News
7.8 WuXi AppTec
7.8.1 WuXi AppTec Corporate Summary
7.8.2 WuXi AppTec Business Overview
7.8.3 WuXi AppTec Cellular and Gene Therapy CDMO Major Product Offerings
7.8.4 WuXi AppTec Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.8.5 WuXi AppTec Key News
7.9 Pharmaron
7.9.1 Pharmaron Corporate Summary
7.9.2 Pharmaron Business Overview
7.9.3 Pharmaron Cellular and Gene Therapy CDMO Major Product Offerings
7.9.4 Pharmaron Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.9.5 Pharmaron Key News
7.10 OBiO
7.10.1 OBiO Corporate Summary
7.10.2 OBiO Business Overview
7.10.3 OBiO Cellular and Gene Therapy CDMO Major Product Offerings
7.10.4 OBiO Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.10.5 OBiO Key News
7.11 Cell Therapies
7.11.1 Cell Therapies Corporate Summary
7.11.2 Cell Therapies Business Overview
7.11.3 Cell Therapies Cellular and Gene Therapy CDMO Major Product Offerings
7.11.4 Cell Therapies Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.11.5 Cell Therapies Key News
7.12 AGC Biologics
7.12.1 AGC Biologics Corporate Summary
7.12.2 AGC Biologics Business Overview
7.12.3 AGC Biologics Cellular and Gene Therapy CDMO Major Product Offerings
7.12.4 AGC Biologics Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.12.5 AGC Biologics Key News
7.13 Cytiva
7.13.1 Cytiva Corporate Summary
7.13.2 Cytiva Business Overview
7.13.3 Cytiva Cellular and Gene Therapy CDMO Major Product Offerings
7.13.4 Cytiva Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.13.5 Cytiva Key News
7.14 Helixmith
7.14.1 Helixmith Corporate Summary
7.14.2 Helixmith Business Overview
7.14.3 Helixmith Cellular and Gene Therapy CDMO Major Product Offerings
7.14.4 Helixmith Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.14.5 Helixmith Key News
7.15 ThermoGenesis
7.15.1 ThermoGenesis Corporate Summary
7.15.2 ThermoGenesis Business Overview
7.15.3 ThermoGenesis Cellular and Gene Therapy CDMO Major Product Offerings
7.15.4 ThermoGenesis Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.15.5 ThermoGenesis Key News
7.16 Anemocyte
7.16.1 Anemocyte Corporate Summary
7.16.2 Anemocyte Business Overview
7.16.3 Anemocyte Cellular and Gene Therapy CDMO Major Product Offerings
7.16.4 Anemocyte Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.16.5 Anemocyte Key News
7.17 Thermo Fisher Scientific
7.17.1 Thermo Fisher Scientific Corporate Summary
7.17.2 Thermo Fisher Scientific Business Overview
7.17.3 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Major Product Offerings
7.17.4 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.17.5 Thermo Fisher Scientific Key News
7.18 CBM
7.18.1 CBM Corporate Summary
7.18.2 CBM Business Overview
7.18.3 CBM Cellular and Gene Therapy CDMO Major Product Offerings
7.18.4 CBM Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.18.5 CBM Key News
7.19 Bio Elpida
7.19.1 Bio Elpida Corporate Summary
7.19.2 Bio Elpida Business Overview
7.19.3 Bio Elpida Cellular and Gene Therapy CDMO Major Product Offerings
7.19.4 Bio Elpida Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.19.5 Bio Elpida Key News
7.20 Genezen
7.20.1 Genezen Corporate Summary
7.20.2 Genezen Business Overview
7.20.3 Genezen Cellular and Gene Therapy CDMO Major Product Offerings
7.20.4 Genezen Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.20.5 Genezen Key News
7.21 CCRM
7.21.1 CCRM Corporate Summary
7.21.2 CCRM Business Overview
7.21.3 CCRM Cellular and Gene Therapy CDMO Major Product Offerings
7.21.4 CCRM Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.21.5 CCRM Key News
7.22 RoslinCT
7.22.1 RoslinCT Corporate Summary
7.22.2 RoslinCT Business Overview
7.22.3 RoslinCT Cellular and Gene Therapy CDMO Major Product Offerings
7.22.4 RoslinCT Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.22.5 RoslinCT Key News
7.23 GenScript ProBio
7.23.1 GenScript ProBio Corporate Summary
7.23.2 GenScript ProBio Business Overview
7.23.3 GenScript ProBio Cellular and Gene Therapy CDMO Major Product Offerings
7.23.4 GenScript ProBio Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.23.5 GenScript ProBio Key News
7.24 Oxford BioMedica
7.24.1 Oxford BioMedica Corporate Summary
7.24.2 Oxford BioMedica Business Overview
7.24.3 Oxford BioMedica Cellular and Gene Therapy CDMO Major Product Offerings
7.24.4 Oxford BioMedica Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.24.5 Oxford BioMedica Key News
7.25 Porton Pharma Solutions
7.25.1 Porton Pharma Solutions Corporate Summary
7.25.2 Porton Pharma Solutions Business Overview
7.25.3 Porton Pharma Solutions Cellular and Gene Therapy CDMO Major Product Offerings
7.25.4 Porton Pharma Solutions Cellular and Gene Therapy CDMO Revenue in Global Market (2018-2023)
7.25.5 Porton Pharma Solutions Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cellular and Gene Therapy CDMO Market Opportunities & Trends in Global Market
Table 2. Cellular and Gene Therapy CDMO Market Drivers in Global Market
Table 3. Cellular and Gene Therapy CDMO Market Restraints in Global Market
Table 4. Key Players of Cellular and Gene Therapy CDMO in Global Market
Table 5. Top Cellular and Gene Therapy CDMO Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cellular and Gene Therapy CDMO Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cellular and Gene Therapy CDMO Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cellular and Gene Therapy CDMO Product Type
Table 9. List of Global Tier 1 Cellular and Gene Therapy CDMO Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cellular and Gene Therapy CDMO Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Cellular and Gene Therapy CDMO Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cellular and Gene Therapy CDMO Revenue in Global (US$, Mn), 2023-2032
Table 14. By Application ? Global Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Cellular and Gene Therapy CDMO Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cellular and Gene Therapy CDMO Revenue in Global (US$, Mn), 2023-2032
Table 17. By Region ? Global Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Cellular and Gene Therapy CDMO Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cellular and Gene Therapy CDMO Revenue (US$, Mn), 2023-2032
Table 20. By Country - North America Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2023-2032
Table 22. By Country - Europe Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2023-2032
Table 24. By Region - Asia Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2023-2032
Table 26. By Country - South America Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2023-2032
Table 28. By Country - Middle East & Africa Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2023-2032
Table 30. Catalent Corporate Summary
Table 31. Catalent Cellular and Gene Therapy CDMO Product Offerings
Table 32. Catalent Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 33. Lonza Corporate Summary
Table 34. Lonza Cellular and Gene Therapy CDMO Product Offerings
Table 35. Lonza Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 36. Charles River Corporate Summary
Table 37. Charles River Cellular and Gene Therapy CDMO Product Offerings
Table 38. Charles River Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 39. The Discovery Labs Corporate Summary
Table 40. The Discovery Labs Cellular and Gene Therapy CDMO Product Offerings
Table 41. The Discovery Labs Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 42. BIOCENTRIQ Corporate Summary
Table 43. BIOCENTRIQ Cellular and Gene Therapy CDMO Product Offerings
Table 44. BIOCENTRIQ Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 45. FUJIFILM Diosynth Biotechnologies Corporate Summary
Table 46. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Offerings
Table 47. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 48. Exothera Corporate Summary
Table 49. Exothera Cellular and Gene Therapy CDMO Product Offerings
Table 50. Exothera Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 51. WuXi AppTec Corporate Summary
Table 52. WuXi AppTec Cellular and Gene Therapy CDMO Product Offerings
Table 53. WuXi AppTec Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 54. Pharmaron Corporate Summary
Table 55. Pharmaron Cellular and Gene Therapy CDMO Product Offerings
Table 56. Pharmaron Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 57. OBiO Corporate Summary
Table 58. OBiO Cellular and Gene Therapy CDMO Product Offerings
Table 59. OBiO Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 60. Cell Therapies Corporate Summary
Table 61. Cell Therapies Cellular and Gene Therapy CDMO Product Offerings
Table 62. Cell Therapies Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 63. AGC Biologics Corporate Summary
Table 64. AGC Biologics Cellular and Gene Therapy CDMO Product Offerings
Table 65. AGC Biologics Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 66. Cytiva Corporate Summary
Table 67. Cytiva Cellular and Gene Therapy CDMO Product Offerings
Table 68. Cytiva Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 69. Helixmith Corporate Summary
Table 70. Helixmith Cellular and Gene Therapy CDMO Product Offerings
Table 71. Helixmith Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 72. ThermoGenesis Corporate Summary
Table 73. ThermoGenesis Cellular and Gene Therapy CDMO Product Offerings
Table 74. ThermoGenesis Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 75. Anemocyte Corporate Summary
Table 76. Anemocyte Cellular and Gene Therapy CDMO Product Offerings
Table 77. Anemocyte Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 78. Thermo Fisher Scientific Corporate Summary
Table 79. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product Offerings
Table 80. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 81. CBM Corporate Summary
Table 82. CBM Cellular and Gene Therapy CDMO Product Offerings
Table 83. CBM Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 84. Bio Elpida Corporate Summary
Table 85. Bio Elpida Cellular and Gene Therapy CDMO Product Offerings
Table 86. Bio Elpida Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 87. Genezen Corporate Summary
Table 88. Genezen Cellular and Gene Therapy CDMO Product Offerings
Table 89. Genezen Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 90. CCRM Corporate Summary
Table 91. CCRM Cellular and Gene Therapy CDMO Product Offerings
Table 92. CCRM Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 93. RoslinCT Corporate Summary
Table 94. RoslinCT Cellular and Gene Therapy CDMO Product Offerings
Table 95. RoslinCT Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 96. GenScript ProBio Corporate Summary
Table 97. GenScript ProBio Cellular and Gene Therapy CDMO Product Offerings
Table 98. GenScript ProBio Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 99. Oxford BioMedica Corporate Summary
Table 100. Oxford BioMedica Cellular and Gene Therapy CDMO Product Offerings
Table 101. Oxford BioMedica Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 102. Porton Pharma Solutions Corporate Summary
Table 103. Porton Pharma Solutions Cellular and Gene Therapy CDMO Product Offerings
Table 104. Porton Pharma Solutions Cellular and Gene Therapy CDMO Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Cellular and Gene Therapy CDMO Segment by Type in 2022
Figure 2. Cellular and Gene Therapy CDMO Segment by Application in 2022
Figure 3. Global Cellular and Gene Therapy CDMO Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cellular and Gene Therapy CDMO Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Cellular and Gene Therapy CDMO Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cellular and Gene Therapy CDMO Revenue in 2022
Figure 8. By Type - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
Figure 9. By Application - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
Figure 10. By Region - Global Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
Figure 11. By Country - North America Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
Figure 12. US Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 13. Canada Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 14. Mexico Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 15. By Country - Europe Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
Figure 16. Germany Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 17. France Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 18. U.K. Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 19. Italy Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 20. Russia Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 21. Nordic Countries Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 22. Benelux Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 23. By Region - Asia Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
Figure 24. China Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 25. Japan Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 26. South Korea Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 27. Southeast Asia Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 28. India Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 29. By Country - South America Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
Figure 30. Brazil Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 31. Argentina Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 32. By Country - Middle East & Africa Cellular and Gene Therapy CDMO Revenue Market Share, 2018-2032
Figure 33. Turkey Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 34. Israel Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 35. Saudi Arabia Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 36. UAE Cellular and Gene Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 37. Catalent Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Lonza Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Charles River Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. The Discovery Labs Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. BIOCENTRIQ Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Exothera Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. WuXi AppTec Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pharmaron Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. OBiO Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cell Therapies Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AGC Biologics Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cytiva Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Helixmith Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. ThermoGenesis Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Anemocyte Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. CBM Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Bio Elpida Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Genezen Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. CCRM Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. RoslinCT Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. GenScript ProBio Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Oxford BioMedica Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Porton Pharma Solutions Cellular and Gene Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
